Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions

American Journal of Pathology

Volumn 176, Issue 3, 2010, Pages 1169-1180

  Ciarimboli, Giuliano ^a   Deuster, Dirk ^a   Knief, Arne ^a   Sperling, Michael ^b   Holtkamp, Michael ^b   Edemir, Bayram ^a   Pavenstädt, Hermann ^a   Lanvers Kaminsky, Claudia ^a   Zehnhoff Dinnesen, Antoinette Am ^a   Schinkel, Alfred H ^c   Koepsell, Hermann ^d   Jürgens, Heribert ^a   Schlatter, Eberhard ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CISPLATIN; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCHLEA; HAIR CELL; HEARING; HUMAN; HUMAN CELL; KIDNEY FUNCTION; MALE; MEASUREMENT; MOUSE; NEPHROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OTOTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 77749273763     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090610     Document Type: Article

References (36)

1. Ramesh G, Reeves WB: TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 2002, 110:835-842
2. Rabik CA, Dolan ME: Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 2007, 33:9-23
3. Pabla N, Dong Z: Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 2008, 73:994-1007
4. Skinner R: Best practice in assessing ototoxicity in children with cancer. Eur J Cancer 2004, 40:2352-2354
5. Ramirez-Camacho R, Garcia-Berrocal JR, Trinidad A, Verdaguer JM, and Nevado J: Blebs in inner and outer hair cells: a pathophysiological hypothesis. J Laryngol Otol 2008, 122:1151-1155
6. Larson CA, Blair BG, Safaei R, Howell SB: The role of the mammalian copper transporter 1 in the cellular accumulation of platinum-based drugs. Mol Pharmacol 2009, 75:324-330
7. Pabla N, Murphy RF, Liu K, Dong Z: The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity. Am J Physiol Renal Physiol 2009, 296:F505-F511
8. Ciarimboli G, Ludwig T, Lang D, Pavenstadt H, Koepsell H, Piechota HJ, Haier J, Jaehde U, Zisowsky J, Schlatter E: Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. Am J Pathol 2005, 167:1477-1484
9. Yonezawa A, Masuda S, Nishihara K, Yano I, Katsura T, Inui K: Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat. Biochem Pharmacol 2005, 70:1823-1831
10. Motohashi H, Sakurai Y, Saito H, Masuda S, Urakami Y, Goto M, Fukatsu A, Ogawa O, Inui KK: Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J Am Soc Nephrol 2002, 13:866-874
11. Koepsell H, Endou H: The SLC22 drug transporter family. Pflugers Arch 2004, 447:666-676
12. Koepsell H, Schmitt BM, Gorboulev V: Organic cation transporters. Rev Physiol Biochem Pharmacol 2003, 150:36-90
13. Jonker JW, Wagenaar E, Van Eijl S, Schinkel AH: Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations. Mol Cell Biol 2003, 23:7902-7908
14. Hardie NA, MacDonald G, Rubel EW: A new method for imaging and 3D reconstruction of mammalian cochlea by fluorescent confocal microscopy. Brain Res 2004, 1000:200-210
15. Lee WK, Reichold M, Edemir B, Ciarimboli G, Warth R, Koepsell H, Thévenod F: The organic cation transporters OCT1, 2, and 3 mediate high affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule. Am J Physiol Renal Physiol 2009, 296:F1504-F1513
16. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63
17. Tada H, Shiho O, Kuroshima K, Koyama M, Tsukamoto K: An improved colorimetric assay for interleukin 2. J Immunol Methods 1986, 93:157-165
18. -ΔΔC(T) method. Methods 2001, 25:402-408
19. Hughes J, Gobe G: Identification and quantification of apoptosis in the kidney using morphology, biochemical and molecular markers. Nephrology 2007, 12:452-458
20. Alnouti Y, Petrick JS, Klaassen CD: Tissue distribution and ontogeny of organic cation transporters in mice. Drug Metab Dispos 2006, 34:477-482
21. Kuo YM, Gybina AA, Pyatskowit JW, Gitschier J, Prohaska JR: Copper transport protein (Ctr1) levels in mice are tissue specific and dependent on copper status. J Nutr 2006, 136:21-26
22. Yokoo S, Yonezawa A, Masuda S, Fukatsu A, Katsura T, Inui K: Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity. Biochem Pharmacol 2007, 74:477-487
23. Ludwig T, Riethmuller C, Gekle M, Schwerdt G, Oberleithner H: Nephrotoxicity of platinum complexes is related to basolateral organic cation transport. Kidney Int 2004, 66:196-202
24. Wang D, Lippard SJ: Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 2005, 4:307-320
25. Yonezawa A, Masuda S, Yokoo S, Katsura T, Inui K: Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family). J Pharmacol Exp Ther 2006, 319:879-886
26. Safaei R, Howell SB: Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. Crit Rev Oncol Hematol 2005, 53:13-23
27. Kim SW, Lee JU, Nah MY, Kang DG, Ahn KY, Lee HS, Choi KC: Cisplatin decreases the abundance of aquaporin water channels in rat kidney. J Am Soc Nephrol 2001, 12:875-882
28. Pasic TR, Dobie RA: Cisplatinum ototoxicity in children. Laryngoscope 1991, 101:985-991
29. Sha SH, Taylor R, Forge A, Schacht J: Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res 2001, 155:1-8
30. + exchanger NHE3. Am J Physiol Cell Physiol 2000, 279:C1918-C1924
31. + exchanger supports proximal tubular protein reabsorption in vivo. Am J Physiol Renal Physiol 2004, 287:F469-F473
32. Zhang S, Lovejoy KS, Shima JE, Lagpacan LL, Shu Y, Lapuk A, Chen Y, Komori T, Gray JW, Chen X, Lippard SJ, Giacomini KM: Organic cation transporters are determinants of oxaliplatin cytotoxicity. Cancer Res 2006, 66:8847-8857
33. Kerb R: Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Lett 2006, 234:4-33
34. Kalow W, Endrenyi L, Tang B: Repeat administration of drugs as a means to assess the genetic component in pharmacological variability. Pharmacology 1999, 58:281-284
35. Ciarimboli G: Organic cation transporters. Xenobiotica 2008, 38: 936-971
36. Filipski KK, Mathijssen RH, Mikkelsen TS, Schinkel AH, Sparreboom A: Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity. Clin Pharmacol Ther 2009, 86:396-402